DocGo (NASDAQ:DCGO) Price Target Cut to $1.00 by Analysts at Needham & Company LLC

DocGo (NASDAQ:DCGO) had its price objective decreased by Needham & Company LLC to $1.00 in a research note issued on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC‘s price objective points to a potential upside of 297.14% from the stock’s current price.

Several other research firms also recently weighed in on DCGO. Canaccord Genuity Group reissued a “hold” rating and issued a $1.00 price target on shares of DocGo in a research note on Tuesday, August 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a research note on Monday, September 14th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $1.50.

DocGo Stock Up 2.8%

DCGO opened at $0.25 on Tuesday. The company has a market cap of $24.91 million, a PE ratio of -0.13 and a beta of 1.03. DocGo has a twelve month low of $0.21 and a twelve month high of $1.17. The company has a 50-day moving average price of $0.33 and a 200 day moving average price of $0.56.

DocGo (NASDAQ:DCGO) last announced its earnings results on Monday, November 9th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.06). DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%. The business had revenue of $73.43 million for the quarter, compared to analyst estimates of $77.24 million. As a group, sell-side analysts expect that DocGo will post -0.22 earnings per share for the current year.

Institutional Trading of DocGo

Several hedge funds have recently made changes to their positions in the company. Diversify Advisory Services LLC acquired a new stake in shares of DocGo during the 2nd quarter worth approximately $53,000. Empowered Funds LLC purchased a new stake in shares of DocGo during the 2nd quarter valued at approximately $79,000. Ieq Capital LLC acquired a new position in DocGo in the second quarter valued at approximately $126,000. Marquette Asset Management LLC acquired a new position in DocGo in the second quarter valued at approximately $175,000. Finally, GSA Capital Partners LLP purchased a new position in DocGo in the second quarter worth approximately $517,000. Hedge funds and other institutional investors own 56.44% of the company’s stock.

About DocGo

DocGo Inc (NASDAQ:DCGO) is a healthcare services company that delivers medical care and related support outside traditional healthcare facilities. Its platform combines mobile medical services, technology and logistics to help healthcare providers, government agencies and other organizations improve access to care.

The company provides mobile health services that can include in-home and community-based clinical care, preventive services, diagnostic testing, vaccinations and care coordination.